List of articles with "FDA"

Replimune Class Action

Replimune Class Action

Class Action FDA Replimune Group
Glucommander Pediatrics

Glucommander Pediatrics

USA Atlanta FDA Glytec Glucommander
WuXi Biologics FDA Success

WuXi Biologics FDA Success

China FDA Wuxi WuXi Biologics GMP Inspection
FDA's Ban on Animal Testing

FDA's Ban on Animal Testing

United States Washington FDA animal testing Humane World for Animals
Beta Bionics Lawsuit

Beta Bionics Lawsuit

USA San Francisco FDA Beta Bionics iLet
Samsung Galaxy Buds Hearing Aid

Samsung Galaxy Buds Hearing Aid

FDA Samsung Galaxy Buds
OncoC4's Cesalatamig Receives Fast Track

OncoC4's Cesalatamig Receives Fast Track

USA FDA Rockville OncoC4 Cesalatamig
Capricor Class Action Alert

Capricor Class Action Alert

United States San Francisco FDA Securities Class Action Capricor Therapeutics
Biohaven Investigation

Biohaven Investigation

USA New York FDA Biohaven BHV-7000
CIMZIA Breakthrough Designation

CIMZIA Breakthrough Designation

USA Atlanta FDA APS CIMZIA
BPC-157 FDA Panel Vote

BPC-157 FDA Panel Vote

United States FDA Scottsdale BPC-157 Promise
FDA Approval for AP308

FDA Approval for AP308

China Shanghai FDA IgA nephropathy Alebund
FDA Clearance for NanoZoomer

FDA Clearance for NanoZoomer

Japan FDA Hamamatsu NanoZoomer
FDA Inspection Data Insights

FDA Inspection Data Insights

United States FDA Salt Lake City Quality Management compliance issues
Cambrex High Point Expands

Cambrex High Point Expands

USA FDA Cambrex High Point
Cambrex High Point Inspections

Cambrex High Point Inspections

USA FDA High Point PMDA Cambrex High Point
Cambrex High Point Inspections

Cambrex High Point Inspections

USA FDA Cambrex High Point TGA
Implantica's Capital Day

Implantica's Capital Day

Sweden FDA Stockholm Implantica RefluxStop
Photocure and FDA Reclassification

Photocure and FDA Reclassification

USA FDA Oslo Photocure Cysview
Radnostix Q2 FY2026 Report

Radnostix Q2 FY2026 Report

USA FDA Idaho Falls Radnostix Lucerno Dynamics
GRAIL's Cancer Test Review

GRAIL's Cancer Test Review

United States FDA Menlo Park GRAIL Galleri
Altria Group Investigation

Altria Group Investigation

USA New York Levi & Korsinsky FDA Altria Group
Capricor Fraud Investigation

Capricor Fraud Investigation

United States Los Angeles Securities Fraud FDA Capricor Therapeutics
Capricor Under Investigation

Capricor Under Investigation

United States New York FDA deramiocel Capricor
Aardvark Therapeutics Under Fire

Aardvark Therapeutics Under Fire

USA San Francisco FDA Aardvark Therapeutics ARD-101
Support for Peptide Access

Support for Peptide Access

FDA peptides Peppies
EDETEK's New Program

EDETEK's New Program

USA FDA Clinical Trials Princeton EDETEK
Sobi's NASP Update

Sobi's NASP Update

USA FDA Stockholm Sobi NASP
Sobi's FDA Response

Sobi's FDA Response

USA FDA Stockholm Sobi NASP
Aardvark Therapeutics Drama

Aardvark Therapeutics Drama

United States San Francisco FDA Aardvark Therapeutics ARD-101
Aidoc's AI Radiology Progress

Aidoc's AI Radiology Progress

United States AI New York FDA Aidoc
UpDoc's AI Platform

UpDoc's AI Platform

United States FDA Palo Alto AI Platform UpDoc
FDA Pharmaceutical Warnings

FDA Pharmaceutical Warnings

United States Raleigh FDA Compliance pharmaceutical
MIT Acquires Cellmyx

MIT Acquires Cellmyx

United States Irvine FDA Micro Imaging Technology Cellmyx
CenExel in Psychedelics

CenExel in Psychedelics

United States FDA psychedelics Draper CenExel
TOBY's Alzheimer's Test

TOBY's Alzheimer's Test

USA Austin FDA Alzheimer's Disease TOBY Test
FDA's Revolving Door Issues

FDA's Revolving Door Issues

United States Los Angeles FDA pharmaceutical lawsuits
ImmunityBio Under Fire

ImmunityBio Under Fire

USA San Francisco FDA ImmunityBio IBRX
Aardvark Investor Concerns

Aardvark Investor Concerns

USA San Francisco FDA Aardvark Therapeutics ARD-101
Viatris FDA Acceptance

Viatris FDA Acceptance

United States FDA Pittsburgh Viatris Meloxicam
CytoSorbents Q1 2026 Update

CytoSorbents Q1 2026 Update

USA FDA Princeton CytoSorbents DrugSorb-ATR
Investigation for PepGen

Investigation for PepGen

United States New York FDA Pomerantz Law PepGen
FDA Approves New E-Cigarettes

FDA Approves New E-Cigarettes

Washington FDA E-cigarettes Youth Smoking
FDA Flavored E-Cigs

FDA Flavored E-Cigs

United States Washington, D.C. FDA Truth Initiative EX Program
TransCelerate and FDA Collaboration

TransCelerate and FDA Collaboration

United States Philadelphia FDA Clinical Trials TransCelerate
PepGen Investors Alert

PepGen Investors Alert

United States New York FDA Pomerantz LLP PepGen
Medtech Regulatory Changes

Medtech Regulatory Changes

Canada Vancouver MedTech FDA Ventripoint
Revolutionizing Trials

Revolutionizing Trials

USA Washington FDA Clinical Trials Paradigm Health
AI in QMSR Transition

AI in QMSR Transition

None AI FDA QMSR
Humacyte Investigation

Humacyte Investigation

United States Humacyte FDA New Orleans Kahn Swick

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.